13 Feb SEC FIlings Statement of acquisition of beneficial ownership February 13, 2023 Posted by Ulisses Read more
12 Feb Press Release Scilex Holding Company, a majority-owned subsidiary of Sorrento Therapeutics, Inc., acquires rights to FDA-Approved ELYXYBTM in the U.S. and Canada for the acute treatment of migraine February 12, 2023 Posted by Jitendra ELYXYBTM is a first-line treatment and the only FDA-approved, ready-to-use oral solution for the acute treatment of migraine, with or without aura, in adults.1 The acute migraine drug market size...Read more